150993 20251017144612.0 doi 10.1016/j.ad.2021.02.008 sideral 124206 ART-2021-124206 spa Abadías-Granado, I. Cutaneous and Mucocutaneous Leishmaniasis 2021 Access copy available to the general public Unrestricted Leishmaniasis is a chronic disease caused by flagellate protozoa of the genus Leishmania. It is a global disease, but most cases are seen in South America, the Mediterranean, and some areas of Asia and Africa. The 3 main types of leishmaniasis are cutaneous (the most common), mucocutaneous, and visceral (the most severe). Visceral leishmaniasis is also known as kala-azar. Leishmaniasis is diagnosed by demonstrating the presence of Leishmania amastigotes in clinical specimens using direct microscopic examination or molecular analysis. Various treatments exist, although the evidence supporting the options available for cutaneous leishmaniasis is weak. Both the classical presentation of leishmaniasis and our management of the disease have changed in recent decades because of acquired immune deficiency caused by conditions such as HIV infection or the use of TNF inhibitors. info:eu-repo/semantics/openAccess by-nc-nd https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es 0.279 2021 Pathology and Forensic Medicine 2021 Q3 Dermatology 2021 Q3 1.2 2021 info:eu-repo/semantics/review info:eu-repo/semantics/publishedVersion Diago, A. Universidad de Zaragoza Cerro, P.A. Palma-Ruiz, A.M. Gilaberte, Y. Universidad de Zaragoza (orcid)0000-0001-8034-3617 1007 183 Universidad de Zaragoza Dpto. Medicina, Psiqu. y Derm. Área Dermatología 112, 7 (2021), 601-618 Actas dermo-sifiliogr. Actas Dermo-Sifiliograficas 0001-7310 4155122 http://zaguan.unizar.es/record/150993/files/texto_completo.pdf Versión publicada 2211549 http://zaguan.unizar.es/record/150993/files/texto_completo.jpg?subformat=icon icon Versión publicada oai:zaguan.unizar.es:150993 articulos driver 2025-10-17-14:17:56 ARTICLE